SMART Wealth LLC Takes $180,000 Position in Oscar Health, Inc. (NYSE:OSCR)

SMART Wealth LLC purchased a new position in shares of Oscar Health, Inc. (NYSE:OSCR) during the 4th quarter, Holdings Channel.com reports. The fund purchased 13,419 shares of the company’s stock, valued at approximately $180,000.

A number of other large investors have also recently added to or reduced their stakes in OSCR. State Street Corp raised its holdings in shares of Oscar Health by 6.0% in the 3rd quarter. State Street Corp now owns 5,132,802 shares of the company’s stock valued at $108,867,000 after purchasing an additional 291,335 shares during the period. Geode Capital Management LLC raised its stake in Oscar Health by 11.7% in the third quarter. Geode Capital Management LLC now owns 4,339,640 shares of the company’s stock valued at $92,062,000 after buying an additional 455,205 shares during the period. Hennessy Advisors Inc. lifted its position in shares of Oscar Health by 550.3% in the fourth quarter. Hennessy Advisors Inc. now owns 4,188,400 shares of the company’s stock valued at $56,292,000 after buying an additional 3,544,300 shares during the last quarter. JPMorgan Chase & Co. boosted its stake in shares of Oscar Health by 68.5% during the 3rd quarter. JPMorgan Chase & Co. now owns 2,309,150 shares of the company’s stock worth $48,977,000 after acquiring an additional 938,742 shares during the period. Finally, Charles Schwab Investment Management Inc. increased its holdings in shares of Oscar Health by 20.3% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,600,166 shares of the company’s stock worth $33,940,000 after acquiring an additional 270,223 shares during the last quarter. Institutional investors and hedge funds own 75.70% of the company’s stock.

Insider Transactions at Oscar Health

In related news, CFO Richard Scott Blackley sold 25,279 shares of the firm’s stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $18.08, for a total transaction of $457,044.32. Following the sale, the chief financial officer now owns 881,841 shares of the company’s stock, valued at $15,943,685.28. This trade represents a 2.79 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CAO Victoria Baltrus sold 8,078 shares of the company’s stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $18.08, for a total value of $146,050.24. Following the completion of the transaction, the chief accounting officer now directly owns 146,036 shares of the company’s stock, valued at approximately $2,640,330.88. The trade was a 5.24 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders acquired 1,055,478 shares of company stock valued at $14,432,852 and sold 103,610 shares valued at $1,847,519. 25.11% of the stock is owned by insiders.

Oscar Health Stock Down 6.2 %

OSCR stock opened at $14.78 on Friday. The company’s 50-day moving average price is $15.14 and its two-hundred day moving average price is $16.83. Oscar Health, Inc. has a 12 month low of $13.05 and a 12 month high of $23.79. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. On average, analysts predict that Oscar Health, Inc. will post -0.01 EPS for the current year.

Analysts Set New Price Targets

A number of equities analysts have commented on the stock. Bank of America cut shares of Oscar Health from a “neutral” rating to an “underperform” rating and reduced their price objective for the stock from $21.00 to $13.50 in a research report on Wednesday, November 6th. Jefferies Financial Group started coverage on shares of Oscar Health in a report on Tuesday, December 10th. They issued an “underperform” rating and a $12.00 price target on the stock. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $21.56.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.